Jove
Visualize
Contact Us

Related Experiment Videos

Minimizing cancer risk using molecular techniques: a review

A Vojdani1, M Ghoneum, P Choppa

  • 1Immunosciences Lab, Incorporated, Beverly Hills, California, USA.

Toxicology and Industrial Health
|September 1, 1997
PubMed
Summary

Identifying molecular cancer risk biomarkers enables early intervention with compounds to prevent precancerous stages. Monitoring these biologic flags aids in detecting chemical-induced damage and individual susceptibility, potentially preventing cancer development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The enhancing effects of Biobran/MGN-3, an arabinoxylan rice bran, on healthy old adults' health-related quality of life: a randomized, double-blind, placebo-controlled clinical trial.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2019
Same author

The Epidemiology, treatment, and complication of ameloblastoma in East-Indonesia: 6 years retrospective study.

Medicina oral, patologia oral y cirugia bucal·2017
Same author

Mgn-3/biobran enhances generation of cytotoxic CD8+ T cells via upregulation of dec-205 expression on dendritic cells.

International journal of immunopathology and pharmacology·2015
Same author

Activation of human monocyte-derived dendritic cells in vitro by the biological response modifier arabinoxylan rice bran (MGN-3/Biobran).

International journal of immunopathology and pharmacology·2012
Same author

Synergistic apoptotic effect of arabinoxylan rice bran (MGN-3/Biobran) and curcumin (turmeric) on human multiple myeloma cell line U266 in vitro.

Neoplasma·2011
Same author

Antibodies as predictors of complex autoimmune diseases and cancer.

International journal of immunopathology and pharmacology·2008
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Oncology
  • Molecular Biology
  • Preventive Medicine

Background:

  • Cancer development is a gradual, multi-step process involving genetic and biochemical cellular changes over decades.
  • Chemicals induce approximately 75% of cancers, with individual susceptibility varying due to differences in metabolism and DNA repair.
  • Early intervention during precancerous stages offers opportunities to prevent malignant transformation.

Purpose of the Study:

  • To review molecular markers indicative of enhanced cancer risk.
  • To explore the use of natural and synthetic compounds for early intervention in carcinogenesis.
  • To identify measurable biologic flags signaling precancerous events.

Main Methods:

  • Review of molecular techniques to identify cancer risk biomarkers.

Related Experiment Videos

  • Monitoring specific bodily signs and damage associated with abnormal cell growth.
  • Analysis of genetic and biochemical changes in cells during carcinogenesis.

    • Main Results:

    • Specific molecular markers, including DNA and protein adducts, DNA damage, apoptosis, DNA repair, mitosis, gene activation, antioxidant levels, and immune function, signal exposure to toxic agents.
    • These biomarkers indicate an individual's vulnerability to chemical carcinogens.
    • Early detection of precancerous damage through these markers is possible.

    Conclusions:

    • Measurement of identified biologic markers provides crucial clues to early-stage cancer risk.
    • Early identification of biomarkers and precancerous damage can guide preventive measures.
    • Intervention with compounds at early stages may prevent invasive cancer and save lives.